BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16369667)

  • 1. [Implication of ermX genes in macrolide- and telithromycin-resistance in Corynebacterium jeikeium and Corynebacterium amycolatum].
    Yagüe Guirao G; Mora Peris B; Martínez-Toldos MC; Rodríguez González T; Valero Guillén PL; Segovia Hernández M
    Rev Esp Quimioter; 2005 Sep; 18(3):236-42. PubMed ID: 16369667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.
    Sánchez Hernández J; Mora Peris B; Yagüe Guirao G; Gutiérrez Zufiaurre N; Muñoz Bellido JL; Segovia Hernández M; García Rodríguez JA
    Int J Antimicrob Agents; 2003 Nov; 22(5):492-6. PubMed ID: 14602367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species.
    Ortiz-Pérez A; Martín-de-Hijas NZ; Esteban J; Fernández-Natal MI; García-Cía JI; Fernández-Roblas R
    Microb Drug Resist; 2010 Dec; 16(4):273-7. PubMed ID: 20624090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible macrolide resistance in Corynebacterium jeikeium.
    Rosato AE; Lee BS; Nash KA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1982-9. PubMed ID: 11408212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide, lincosamide, and streptogramin B-constitutive-type resistance in Corynebacterium pseudodiphtheriticum isolated from upper respiratory tract specimens.
    Olender A; Niemcewicz M
    Microb Drug Resist; 2010 Jun; 16(2):119-22. PubMed ID: 20438346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.
    Davis KA; Crawford SA; Fiebelkorn KR; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3059-61. PubMed ID: 15980400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.
    Zhanel GG; Johanson C; Hisanaga T; Mendoza C; Laing N; Noreddin A; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1072-7. PubMed ID: 15531596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci.
    Raney PM; Tenover FC; Carey RB; McGowan JE; Patel JB
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):213-8. PubMed ID: 16545937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide, lincosamide, and streptogramin B resistance in lipophilic Corynebacteria inhabiting healthy human skin.
    Szemraj M; Kwaszewska A; Pawlak R; Szewczyk EM
    Microb Drug Resist; 2014 Oct; 20(5):404-9. PubMed ID: 24735183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G
    Antimicrob Agents Chemother; 1998 May; 42(5):1028-33. PubMed ID: 9593121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.
    Green M; Allen C; Bradley J; Dashefsky B; Gilsdorf JR; Marcon MJ; Schutze GE; Smith C; Walter E; Martin JM; Edwards KA; Barbadora KA; Rumbaugh RM; Wald ER
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2487-9. PubMed ID: 15917551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analytical evaluation of macrolide- and ketolide-resistant Streptococcus pneumoniae--mechanism of action of telithromycin and resistance to it].
    Inoue M; Kaneko K; Nakano R; Sato Y; Arai S
    Jpn J Antibiot; 2004 Oct; 57(5):425-37. PubMed ID: 15655904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.
    Reinert RR; van der Linden M; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3520-2. PubMed ID: 16048973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
    Novotná G; Spízek J; Janata J
    Folia Microbiol (Praha); 2007; 52(6):593-9. PubMed ID: 18450221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
    Javsicas LH; Giguère S; Womble AY
    J Vet Pharmacol Ther; 2010 Aug; 33(4):383-8. PubMed ID: 20646201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.